The use of misoprostol in obstetrics and gynaecology
Authors:
- 4 September 2009
- journal article
- review article
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 116 (s1) , 61-69
Abstract
Misoprostol, although originally introduced as a therapy for gastric ulcers, is now widely used in reproductive health. For some indications it is now the optimal choice, whilst for others it provides an important alternative, especially in low‐resource settings. The optimal dose varies widely from 20 to 600 mcg depending on the indication and gestation. Use of the correct dose is important, too low a dose will be ineffective and overdosage can be dangerous for mother and baby. Evidence‐based information about the safest regimens for multiple pregnancy indications are therefore provided in this review.Keywords
This publication has 50 references indexed in Scilit:
- Misoprostol in addition to routine treatment of postpartum hemorrhage: A hospital-based randomized-controlled trial in Karachi, PakistanBMC Pregnancy and Childbirth, 2008
- Misoprostol: Pharmacokinetic profiles, effects on the uterus and side‐effectsInternational Journal of Gynecology & Obstetrics, 2007
- Misoprostol for the termination of pregnancy up to 12 completed weeks of pregnancyInternational Journal of Gynecology & Obstetrics, 2007
- Cervical priming with misoprostol prior to transcervical proceduresInternational Journal of Gynecology & Obstetrics, 2007
- Sublingual compared with oral and vaginal misoprostol for termination of pregnancy with second‐trimester fetal demiseInternational Journal of Gynecology & Obstetrics, 2007
- Parachute approach to evidence based medicineBMJ, 2006
- Management of miscarriage: expectant, medical, or surgical? Results of randomised controlled trial (miscarriage treatment (MIST) trial)BMJ, 2006
- Medical treatment of missed abortion using misoprostolInternational Journal of Gynecology & Obstetrics, 2004
- Disruption of Prior Uterine Incision following Misoprostol for Labor Induction in Women with Previous Cesarean DeliveryObstetrics & Gynecology, 1998
- A comparative study using two dose regimens (200 μg or 400 μg) of vaginal misoprostol for pre‐operative cervical dilatation in first trimester nulliparaeBJOG: An International Journal of Obstetrics & Gynaecology, 1998